Jacobson Pharma : CHANGE OF COMPANY SECRETARY

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Jacobson Pharma Corporation Limited

雅各臣科研製藥有限公司

(Incorporated under the laws of the Cayman Islands with limited liability)

Stock Code : 2633

CHANGE OF COMPANY SECRETARY

The board (the "Board") of directors (the "Directors") of Jacobson Pharma Corporation Limited (the "Company", together with its subsidiaries, the "Group") hereby announces the appointment of Mr. Yu Chun Kau ("Mr. Yu") as the company secretary of the Company (the "Company Secretary") in place of Mr. Yim Chun Leung ("Mr. Yim") with effect from 1 April 2021.

Mr Yu, aged 48, is currently the Chief Financial Officer of the Group. Mr. Yu possesses extensive experience in accounting, corporate finance, compliance and auditing and had held a number of senior positions in various listed companies and multinational corporations prior to joining the Group in January 2019. Mr. Yu graduated from The Chinese University of Hong Kong with a degree in bachelor of business administration with first class honours in December 1994. In June 2005, he also obtained a degree in master of corporate governance from The Open University of Hong Kong. Mr. Yu was admitted as a fellow member of The Association of Chartered Certified Accountants in November 2002. He was admitted as a fellow member and was registered as a certified public accountant (practising) of the Hong Kong Institute of Certified Public Accountants (formerly known as Hong Kong Society of Accountants) in July 2005 and in October 2002, respectively. In March 2007, he was admitted as a senior international finance manager in the International Financial Management Association. In April 2015, he was also admitted as a fellow member of The Institute of Chartered Accountants in England and Wales. In September 2016, he was admitted as both a fellow member of The Hong Kong Institute of Chartered Secretaries and as a fellow member of The Institute of Chartered Secretaries and Administrators.

- 1 -

Mr. Yim ceases to be the Company Secretary so that he can devote more time to the work of the Board and business of the Group. Mr. Yim will remain as an executive Director as well as his other positions in the Board and the Group. Mr. Yim has confirmed that he has no disagreement with the Board and there is no matter in relation to his cessation as the Company Secretary that needs to be brought to the attention of the shareholders of the Company.

The Board would like to take this opportunity to express its appreciation to Mr. Yim for his valuable contribution to the Group during his tenure of office as the Company Secretary and congratulate Mr. Yu on his new appointment.

By order of the Board

Jacobson Pharma Corporation Limited

YIM Chun Leung

Executive Director

Hong Kong, 1 April 2021

As at the date of this announcement, the Board comprises Mr. Sum Kwong Yip, Derek (also as Chairman and Chief Executive Officer), Mr. Yim Chun Leung and Ms. Pun Yue Wai as executive Directors, Professor Lam Sing Kwong, Simon as non-executive Director, and Dr. Lam Kwing Tong, Alan, Mr. Young Chun Man, Kenneth and Professor Wong Chi Kei, Ian as independent non-executive Directors.

- 2 -